3
Orphan Designations
0 approved, 3 designated
0
FDA Approvals
0
Active Trials
5
Rare Diseases
across 6 areas
0
News (30d)
Quiet
Xenetic Biosciences, Inc. is a company with 3 orphan drug designations across 5 rare diseases.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| acute myeloid leukemia | recombinant human histone H1.3; recombinant human N-bis-met-histone H1.3 | Des.TrialAppr. |
| malignant pancreatic neoplasm | Dornase alpha | Des.TrialAppr. |
| progesterone resistance | cridanimod | Des.TrialAppr. |
| progesterone-receptor negative breast cancer | cridanimod | Des.TrialAppr. |
| progesterone-receptor positive breast cancer | cridanimod | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
27
overlap in 2+ diseases
0/5
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
27
overlap in 2+ diseases
0/5
candidate diseases
0
avg importance: 0
0
affecting portfolio